About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Everbeat Ring ECG Clinical Concordance Study | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT05469542

Everbeat Ring ECG Clinical Concordance Study

This study is a cross-sectional observational study conducted in patients referred for routine ECG, to compare output from the everbeat finger-worn ECG device to standard of care (SOC) 12-lead electro...

Lead sponsor: Grektek Inc.•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Grektek Inc.

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Males or females aged 18 to 90 years.
•Under the care of a board-certified physician and referred for a routine electrocardiogram (ECG)
•Resting heart rate between 50 to 120 beats per minute (BPM).

Exclusion Criteria

•Inability to wear the everbeat ring.
•Prior history of movement disorders including Parkinson's or benign tremors.
•Prior history of allergic skin reactions to metal including stainless steel.

Related studies

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

NCT07547098 · Cardiovascular Diseases (CVD), Chronic Kidney Disease, and more

Is Post-exertional Symptom Exacerbation Specific to Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome? A Study Comparing Patients With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome and Patients With Cardiac Diseases Who Underwent an Exercise Test.

NCT07491315 · Fatigue Syndrome, Chronic, Cardiovascular Diseases

RECRUITINGPhase 1/2

TB-500 (Thymosin Beta 4 17-23 Fragment) for Cardiovascular Biomarkers in Stable ASCVD

NCT07487363 · Atherosclerotic Cardiovascular Diseases, Endothelial Dysfunction

Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry

NCT07256249 · Cardiovascular Diseases

The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases

NCT06909773 · Cardiovascular Diseases

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 21, 2022Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment65

Start dateAug 2022

Last updatedJul 21, 2022

Condition

Cardiovascular Diseases

Locations shown

BKLYNCardio

Brooklyn, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 21, 2022Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions